Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?

Gal CohenMaya ShavitNetanella MillerRimon MoranYael YagurOmer WeitznerMichal OvadiaHanoch SchreiberGil Shechter-MaorTal Biron-Shental

Published in: PloS one (2022)

17P might delay preterm delivery in patients with a previous sPTB on an individual level (prolongation of the pregnancy for each patient compared to her previous delivery). Therefore, our results imply that 17P can decrease potential premature delivery complications for patients with a previous sPTB due to PMC or pPROM.

Keyphrases

preterm birth
low birth weight
gestational age
case report
preterm infants
risk assessment
human health